ALDH1 expression has now been widely confirmed as a marker for stem cells in various cancers, enabling the effective identification and sorting of CSCs, offering the potential for more precise future cancer treatments (Toledo-Guzman et al., 2019). This evidence concerns the gene ALDH1A1 and cancer.